Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis brings creative malaria campaign to Pinterest

Invites users to create their own mosquito-killing story
Novartis malaria Pinterest social media campaign

Novartis has turned to Pinterest for a creative malaria awareness campaign that combines infographic 'trading cards' and 48 pinned images that can be viewed as a larger story.

Its Mosquito Gauntlet board on Pinterest has to be viewed in three columns on a desktop or laptop to work properly, but despite not being very mobile friendly it is a striking use of the site.

Novartis hopes to encourage Pinterest users to follow its lead on Mosquito Gauntlet and use its Mosquito Mayhem board create their own story on how to kill the insects.

Meanwhile, the company's M-Force Trading Cards board features “a futuristic task force of super heroes poised to fight malaria” - though whether the likes of Plasmorpheus, Agent Sparrow and Velocibot strike the right note remains to be seen.

Nevertheless, there is a serious message to the campaign, which ties-up with the Novartis-supported Malaria No More charity, which is working to make sure every family in Africa has timely access to the tools they need to prevent, diagnose and treat malaria.

27th November 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....

Infographics